Meibomian Gland Dysfunction (MGD) is the leading cause of dry globally. Clearing constricting and obstructing scar tissue from around Meibomian Gland ducts is the only way to establish and confirm good oil flow.
MGDinnovations' innovative and effective probing protocol allows eye doctors to set up dry eye patients for improved eye moisture and comfort, and is an essential element of dry eye treatment plans.
Company Details
- Employees
- 2
- Address
- 3001 W Swann Ave, Tampa,florida 33609,united States
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- mgdi.com
- Keywords
- ophthalmology, dry eye, medical devices, optometry.
- HQ
- Tampa, Florida
- Competitors
- Raxar Technology Corporation.
Mgdinnovations Questions
Mgdinnovations's website is mgdi.com
Mgdinnovations's LinkedIn profile is https://www.linkedin.com/company/mgdinnovations
Mgdinnovations has
2 employees.
View email and phone details for 2
employees at Mgdinnovations.
Mgdinnovations's industry is
Medical Equipment Manufacturing
Mgdinnovations's top competitors are
Raxar Technology Corporation.
Mgdinnovations's categories are Medical Equipment Manufacturing
